| 0 |
CONJUNCTIVAL FOLLICLES |
11 |
0.3438 |
| 1 |
HYPOTONY MACULOPATHY |
12 |
0.2927 |
| 2 |
INFECTIOUS CRYSTALLINE KERATOPATHY |
8 |
0.2162 |
| 3 |
KERATITIS INTERSTITIAL |
9 |
0.1765 |
| 4 |
OCULAR SURFACE DISEASE |
45 |
0.1601 |
| 5 |
TRABECULECTOMY |
9 |
0.0978 |
| 6 |
INTRAOCULAR PRESSURE FLUCTUATION |
17 |
0.0863 |
| 7 |
CORNEAL NEOVASCULARISATION |
21 |
0.0850 |
| 8 |
CONJUNCTIVAL SCAR |
12 |
0.0795 |
| 9 |
CORNEAL OPACITY |
107 |
0.0783 |
| 10 |
HYPOTONY OF EYE |
28 |
0.0667 |
| 11 |
OPEN ANGLE GLAUCOMA |
39 |
0.0635 |
| 12 |
ANTERIOR CHAMBER FIBRIN |
8 |
0.0620 |
| 13 |
CHOROIDAL DETACHMENT |
34 |
0.0613 |
| 14 |
CORNEAL INFILTRATES |
18 |
0.0573 |
| 15 |
PALPABLE PURPURA |
15 |
0.0547 |
| 16 |
PRODUCT DROPPER ISSUE |
42 |
0.0534 |
| 17 |
SCLERAL HYPERAEMIA |
35 |
0.0514 |
| 18 |
CHOROIDAL EFFUSION |
40 |
0.0498 |
| 19 |
CORNEAL DEGENERATION |
12 |
0.0496 |
| 20 |
INTRAOCULAR PRESSURE INCREASED |
626 |
0.0489 |
| 21 |
GLAUCOMA SURGERY |
12 |
0.0469 |
| 22 |
FLAT ANTERIOR CHAMBER OF EYE |
8 |
0.0447 |
| 23 |
CORNEA VERTICILLATA |
13 |
0.0428 |
| 24 |
CORNEAL OEDEMA |
91 |
0.0406 |
| 25 |
INTRAOCULAR PRESSURE TEST ABNORMAL |
28 |
0.0397 |
| 26 |
ROSACEA |
183 |
0.0392 |
| 27 |
PYELITIS |
8 |
0.0385 |
| 28 |
INTRAOCULAR PRESSURE DECREASED |
20 |
0.0380 |
| 29 |
IRIS ADHESIONS |
19 |
0.0370 |
| 30 |
ANTERIOR CHAMBER DISORDER |
8 |
0.0348 |
| 31 |
TREATMENT FAILURE |
2879 |
0.0347 |
| 32 |
CORNEAL TRANSPLANT |
26 |
0.0332 |
| 33 |
INSTILLATION SITE ERYTHEMA |
17 |
0.0322 |
| 34 |
FIBROADENOMA OF BREAST |
14 |
0.0311 |
| 35 |
MEIBOMIAN GLAND DYSFUNCTION |
14 |
0.0309 |
| 36 |
SHORT STATURE |
8 |
0.0305 |
| 37 |
GROWTH OF EYELASHES |
24 |
0.0303 |
| 38 |
HYPHAEMA |
15 |
0.0287 |
| 39 |
REACTION TO PRESERVATIVES |
23 |
0.0283 |
| 40 |
PUNCTATE KERATITIS |
25 |
0.0272 |
| 41 |
FLOPPY IRIS SYNDROME |
10 |
0.0271 |
| 42 |
ANTERIOR CHAMBER INFLAMMATION |
16 |
0.0269 |
| 43 |
OCULAR HYPERTENSION |
51 |
0.0262 |
| 44 |
PRODUCT CLOSURE REMOVAL DIFFICULT |
26 |
0.0255 |
| 45 |
GLARE |
13 |
0.0253 |
| 46 |
EYE ALLERGY |
37 |
0.0239 |
| 47 |
CORNEAL SCAR |
12 |
0.0239 |
| 48 |
OCULAR VASCULAR DISORDER |
19 |
0.0230 |
| 49 |
CONJUNCTIVITIS ALLERGIC |
34 |
0.0229 |
| 50 |
CORNEAL DEPOSITS |
17 |
0.0228 |
| 51 |
CONJUNCTIVAL HYPERAEMIA |
79 |
0.0221 |
| 52 |
EYELID PAIN |
45 |
0.0221 |
| 53 |
SUPERFICIAL INJURY OF EYE |
24 |
0.0220 |
| 54 |
MAGNETIC RESONANCE IMAGING HEAD ABNORMAL |
14 |
0.0216 |
| 55 |
INSTILLATION SITE PRURITUS |
8 |
0.0212 |
| 56 |
KERATIC PRECIPITATES |
10 |
0.0211 |
| 57 |
FOREIGN BODY SENSATION IN EYES |
131 |
0.0205 |
| 58 |
CORNEAL EROSION |
11 |
0.0204 |
| 59 |
GLAUCOMA |
382 |
0.0198 |
| 60 |
IRIDOCYCLITIS |
61 |
0.0193 |
| 61 |
PRODUCT CONTAINER ISSUE |
161 |
0.0188 |
| 62 |
ENDOCRINE OPHTHALMOPATHY |
16 |
0.0184 |
| 63 |
ERYTHEMA OF EYELID |
98 |
0.0181 |
| 64 |
CORNEAL DISORDER |
37 |
0.0169 |
| 65 |
PERIORBITAL PAIN |
14 |
0.0165 |
| 66 |
PNEUMONIA HAEMOPHILUS |
8 |
0.0165 |
| 67 |
OCULAR HYPERAEMIA |
779 |
0.0164 |
| 68 |
EYE INFECTION BACTERIAL |
9 |
0.0161 |
| 69 |
EYELID IRRITATION |
39 |
0.0155 |
| 70 |
EYE LASER SURGERY |
9 |
0.0152 |
| 71 |
VITRECTOMY |
9 |
0.0151 |
| 72 |
CATARACT NUCLEAR |
10 |
0.0150 |
| 73 |
RETINAL VASCULAR OCCLUSION |
11 |
0.0149 |
| 74 |
EYE COLOUR CHANGE |
15 |
0.0147 |
| 75 |
CYSTOID MACULAR OEDEMA |
27 |
0.0143 |
| 76 |
BLEPHARITIS |
57 |
0.0142 |
| 77 |
CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER |
15 |
0.0141 |
| 78 |
EYE IRRITATION |
812 |
0.0141 |
| 79 |
EYE PAIN |
789 |
0.0140 |
| 80 |
PRODUCT DELIVERY MECHANISM ISSUE |
75 |
0.0139 |
| 81 |
EYELID EXFOLIATION |
11 |
0.0139 |
| 82 |
INSTILLATION SITE IRRITATION |
16 |
0.0135 |
| 83 |
EYELID MARGIN CRUSTING |
39 |
0.0135 |
| 84 |
EYELIDS PRURITUS |
41 |
0.0131 |
| 85 |
CATARACT SUBCAPSULAR |
8 |
0.0131 |
| 86 |
ANGLE CLOSURE GLAUCOMA |
33 |
0.0129 |
| 87 |
OPTIC NERVE INJURY |
15 |
0.0129 |
| 88 |
TOXIC ANTERIOR SEGMENT SYNDROME |
14 |
0.0128 |
| 89 |
CORNEAL PERFORATION |
8 |
0.0127 |
| 90 |
CONJUNCTIVAL OEDEMA |
13 |
0.0126 |
| 91 |
ANTERIOR CHAMBER CELL |
9 |
0.0126 |
| 92 |
REBOUND EFFECT |
142 |
0.0126 |
| 93 |
FOREIGN BODY IN EYE |
12 |
0.0125 |
| 94 |
EYE DISCHARGE |
125 |
0.0120 |
| 95 |
VITREOUS HAEMORRHAGE |
33 |
0.0119 |
| 96 |
EYE INFLAMMATION |
106 |
0.0111 |
| 97 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
73 |
0.0107 |
| 98 |
OCULAR DISCOMFORT |
120 |
0.0107 |
| 99 |
NEPHROGENIC ANAEMIA |
49 |
0.0106 |
| 100 |
PRODUCT CONTAINER SEAL ISSUE |
18 |
0.0103 |
| 101 |
EYE OPERATION |
47 |
0.0102 |
| 102 |
VITREOUS DETACHMENT |
22 |
0.0101 |
| 103 |
MACULAR OEDEMA |
56 |
0.0100 |
| 104 |
HYPERPARATHYROIDISM SECONDARY |
25 |
0.0100 |
| 105 |
EYE PRURITUS |
334 |
0.0099 |
| 106 |
ULCERATIVE KERATITIS |
27 |
0.0098 |
| 107 |
HERPES OPHTHALMIC |
13 |
0.0098 |
| 108 |
ABNORMAL SENSATION IN EYE |
41 |
0.0095 |
| 109 |
VITREOUS OPACITIES |
8 |
0.0095 |
| 110 |
HYPERAEMIA |
18 |
0.0091 |
| 111 |
EYELID DISORDER |
21 |
0.0091 |
| 112 |
BLINDNESS UNILATERAL |
123 |
0.0087 |
| 113 |
VISUAL FIELD DEFECT |
63 |
0.0087 |
| 114 |
SKIN WARM |
50 |
0.0086 |
| 115 |
IRITIS |
26 |
0.0085 |
| 116 |
PRODUCT DEPOSIT |
13 |
0.0083 |
| 117 |
SWELLING OF EYELID |
52 |
0.0083 |
| 118 |
KERATOPATHY |
13 |
0.0082 |
| 119 |
SKIN DISCOMFORT |
22 |
0.0081 |
| 120 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
21 |
0.0080 |
| 121 |
HALO VISION |
9 |
0.0080 |
| 122 |
EYE INJURY |
24 |
0.0079 |
| 123 |
DACRYOSTENOSIS ACQUIRED |
10 |
0.0077 |
| 124 |
VITREOUS FLOATERS |
76 |
0.0077 |
| 125 |
SKIN SENSITISATION |
8 |
0.0077 |
| 126 |
RETINAL DISORDER |
20 |
0.0077 |
| 127 |
CONJUNCTIVITIS |
142 |
0.0076 |
| 128 |
KERATITIS |
23 |
0.0076 |
| 129 |
EYELID SKIN DRYNESS |
9 |
0.0074 |
| 130 |
MENISCUS INJURY |
45 |
0.0073 |
| 131 |
PHOTOPHOBIA |
137 |
0.0073 |
| 132 |
HELICOBACTER GASTRITIS |
9 |
0.0073 |
| 133 |
LACRIMATION INCREASED |
216 |
0.0071 |
| 134 |
RETINAL ARTERY OCCLUSION |
18 |
0.0071 |
| 135 |
METAMORPHOPSIA |
13 |
0.0070 |
| 136 |
RETINAL DEGENERATION |
9 |
0.0069 |
| 137 |
INSTILLATION SITE PAIN |
17 |
0.0069 |
| 138 |
UVEITIS |
90 |
0.0066 |
| 139 |
OPTIC NEUROPATHY |
14 |
0.0066 |
| 140 |
CORNEAL ABRASION |
9 |
0.0066 |
| 141 |
RETINAL DETACHMENT |
58 |
0.0063 |
| 142 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
10 |
0.0062 |
| 143 |
NIGHT BLINDNESS |
10 |
0.0062 |
| 144 |
DRY EYE |
307 |
0.0061 |
| 145 |
VISUAL ACUITY REDUCED |
204 |
0.0061 |
| 146 |
EYE SWELLING |
228 |
0.0061 |
| 147 |
NORMOCYTIC ANAEMIA |
9 |
0.0061 |
| 148 |
OPHTHALMIC HERPES ZOSTER |
11 |
0.0061 |
| 149 |
VITRITIS |
11 |
0.0059 |
| 150 |
HYPERSENSITIVITY VASCULITIS |
15 |
0.0057 |
| 151 |
OPTIC NERVE DISORDER |
9 |
0.0056 |
| 152 |
RETINAL VEIN OCCLUSION |
16 |
0.0056 |
| 153 |
WRONG PRODUCT ADMINISTERED |
37 |
0.0055 |
| 154 |
SMALL INTESTINAL HAEMORRHAGE |
11 |
0.0055 |
| 155 |
ASTHENOPIA |
30 |
0.0055 |
| 156 |
EYE INFECTION |
60 |
0.0053 |
| 157 |
ASTIGMATISM |
8 |
0.0053 |
| 158 |
EYE DISORDER |
173 |
0.0053 |
| 159 |
CONJUNCTIVAL HAEMORRHAGE |
20 |
0.0052 |
| 160 |
BLOOD CHLORIDE INCREASED |
9 |
0.0052 |
| 161 |
ELECTRIC SHOCK SENSATION |
14 |
0.0050 |
| 162 |
EYELID OEDEMA |
58 |
0.0050 |
| 163 |
BRONCHIAL OBSTRUCTION |
7 |
0.0050 |
| 164 |
SINUS NODE DYSFUNCTION |
9 |
0.0049 |
| 165 |
OPTIC ATROPHY |
8 |
0.0049 |
| 166 |
PULMONARY ARTERIAL PRESSURE INCREASED |
8 |
0.0049 |
| 167 |
PHOTOPSIA |
31 |
0.0049 |
| 168 |
EYE OEDEMA |
12 |
0.0049 |
| 169 |
ENDOPHTHALMITIS |
29 |
0.0048 |
| 170 |
VISION BLURRED |
656 |
0.0048 |
| 171 |
RETINAL OEDEMA |
9 |
0.0047 |
| 172 |
SKIN TIGHTNESS |
22 |
0.0047 |
| 173 |
PRODUCT USE COMPLAINT |
71 |
0.0045 |
| 174 |
PRODUCT PACKAGE ASSOCIATED INJURY |
10 |
0.0045 |
| 175 |
DIABETIC RETINOPATHY |
15 |
0.0044 |
| 176 |
BLOOD LOSS ANAEMIA |
10 |
0.0044 |
| 177 |
PERIARTHRITIS |
10 |
0.0044 |
| 178 |
CUTANEOUS VASCULITIS |
16 |
0.0044 |
| 179 |
CATARACT OPERATION |
26 |
0.0044 |
| 180 |
ESSENTIAL HYPERTENSION |
8 |
0.0044 |
| 181 |
VASODILATATION |
11 |
0.0044 |
| 182 |
HAEMORRHAGE URINARY TRACT |
11 |
0.0043 |
| 183 |
CATARACT |
257 |
0.0043 |
| 184 |
SKIN INJURY |
14 |
0.0042 |
| 185 |
HYPOTONIA |
42 |
0.0042 |
| 186 |
MYOPIA |
10 |
0.0042 |
| 187 |
DYSLIPIDAEMIA |
21 |
0.0041 |
| 188 |
EYELID PTOSIS |
42 |
0.0041 |
| 189 |
RETINAL TEAR |
10 |
0.0041 |
| 190 |
VOCAL CORD DISORDER |
8 |
0.0041 |
| 191 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
284 |
0.0040 |
| 192 |
REBOUND ACID HYPERSECRETION |
12 |
0.0040 |
| 193 |
BLINDNESS TRANSIENT |
29 |
0.0039 |
| 194 |
PERIORBITAL SWELLING |
22 |
0.0039 |
| 195 |
NASAL DRYNESS |
24 |
0.0038 |
| 196 |
EYE CONTUSION |
8 |
0.0038 |
| 197 |
HYPERSENSITIVITY |
699 |
0.0038 |
| 198 |
DERMATITIS EXFOLIATIVE GENERALISED |
13 |
0.0037 |
| 199 |
END STAGE RENAL DISEASE |
68 |
0.0037 |
| 200 |
ERYTHEMA |
763 |
0.0037 |
| 201 |
BLINDNESS |
151 |
0.0037 |
| 202 |
HORDEOLUM |
16 |
0.0037 |
| 203 |
BLOOD BICARBONATE DECREASED |
7 |
0.0037 |
| 204 |
EYE HAEMORRHAGE |
49 |
0.0037 |
| 205 |
RETINAL HAEMORRHAGE |
26 |
0.0036 |
| 206 |
CHEMICAL BURN OF SKIN |
9 |
0.0035 |
| 207 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
9 |
0.0035 |
| 208 |
HYPOTHERMIA |
35 |
0.0035 |
| 209 |
MIOSIS |
27 |
0.0034 |
| 210 |
MACULAR DEGENERATION |
40 |
0.0033 |
| 211 |
VISUAL IMPAIRMENT |
404 |
0.0033 |
| 212 |
BLOOD MAGNESIUM DECREASED |
28 |
0.0032 |
| 213 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
8 |
0.0032 |
| 214 |
DERMATITIS CONTACT |
36 |
0.0032 |
| 215 |
DUODENAL ULCER HAEMORRHAGE |
9 |
0.0031 |
| 216 |
HYPERKERATOSIS |
17 |
0.0031 |
| 217 |
FLUSHING |
312 |
0.0031 |
| 218 |
RASH MACULAR |
104 |
0.0030 |
| 219 |
RETINOPATHY |
11 |
0.0029 |
| 220 |
LARGE INTESTINE POLYP |
20 |
0.0029 |
| 221 |
HYPOPNOEA |
10 |
0.0029 |
| 222 |
ARTERIOSCLEROSIS CORONARY ARTERY |
19 |
0.0029 |
| 223 |
PRODUCT PACKAGING ISSUE |
27 |
0.0028 |
| 224 |
MACULOPATHY |
10 |
0.0028 |
| 225 |
PRODUCT DISPENSING ISSUE |
12 |
0.0028 |
| 226 |
FEELING HOT |
171 |
0.0028 |
| 227 |
PAIN OF SKIN |
74 |
0.0027 |
| 228 |
DEAFNESS NEUROSENSORY |
9 |
0.0027 |
| 229 |
BENIGN PROSTATIC HYPERPLASIA |
14 |
0.0027 |
| 230 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
107 |
0.0027 |
| 231 |
DRY MOUTH |
215 |
0.0026 |
| 232 |
PALLOR |
72 |
0.0026 |
| 233 |
BRADYCARDIA |
140 |
0.0026 |
| 234 |
SKIN BURNING SENSATION |
189 |
0.0026 |
| 235 |
BLOOD POTASSIUM ABNORMAL |
7 |
0.0026 |
| 236 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
10 |
0.0026 |
| 237 |
VITAMIN D DECREASED |
22 |
0.0026 |
| 238 |
RESPIRATORY ACIDOSIS |
10 |
0.0025 |
| 239 |
GLUCOSE TOLERANCE IMPAIRED |
15 |
0.0025 |
| 240 |
PRODUCT ADMINISTRATION ERROR |
50 |
0.0025 |
| 241 |
NOCTURIA |
30 |
0.0025 |
| 242 |
BODY HEIGHT DECREASED |
26 |
0.0024 |
| 243 |
HOSPICE CARE |
24 |
0.0024 |
| 244 |
CEREBRAL HAEMATOMA |
8 |
0.0024 |
| 245 |
SUPRAVENTRICULAR EXTRASYSTOLES |
8 |
0.0024 |
| 246 |
DRY THROAT |
24 |
0.0024 |
| 247 |
PRODUCT LABEL ISSUE |
16 |
0.0024 |
| 248 |
ONYCHOMYCOSIS |
10 |
0.0023 |
| 249 |
CHRONIC KIDNEY DISEASE |
173 |
0.0023 |
| 250 |
NEUROLOGICAL SYMPTOM |
13 |
0.0023 |
| 251 |
PRODUCT CONTAMINATION |
8 |
0.0022 |
| 252 |
DERMATITIS |
47 |
0.0022 |
| 253 |
PRODUCT RESIDUE PRESENT |
12 |
0.0022 |
| 254 |
MYDRIASIS |
28 |
0.0022 |
| 255 |
ONYCHOCLASIS |
15 |
0.0022 |
| 256 |
ELECTROLYTE IMBALANCE |
25 |
0.0021 |
| 257 |
FACIAL PAIN |
19 |
0.0021 |
| 258 |
BLOOD PRESSURE FLUCTUATION |
51 |
0.0021 |
| 259 |
PARANASAL SINUS DISCOMFORT |
8 |
0.0021 |
| 260 |
LIQUID PRODUCT PHYSICAL ISSUE |
15 |
0.0021 |
| 261 |
PURPURA |
18 |
0.0020 |
| 262 |
HAEMOGLOBIN ABNORMAL |
13 |
0.0020 |
| 263 |
EXPIRED DRUG ADMINISTERED |
10 |
0.0020 |
| 264 |
RASH PAPULAR |
45 |
0.0020 |
| 265 |
FLUID INTAKE REDUCED |
10 |
0.0020 |
| 266 |
POOR QUALITY PRODUCT ADMINISTERED |
21 |
0.0020 |
| 267 |
RECALLED PRODUCT ADMINISTERED |
19 |
0.0020 |
| 268 |
DIZZINESS POSTURAL |
19 |
0.0020 |
| 269 |
CONCOMITANT DISEASE AGGRAVATED |
12 |
0.0019 |
| 270 |
PERIPHERAL VASCULAR DISORDER |
10 |
0.0019 |
| 271 |
IMPAIRED DRIVING ABILITY |
22 |
0.0019 |
| 272 |
PHARYNGITIS |
24 |
0.0019 |
| 273 |
APNOEA |
15 |
0.0019 |
| 274 |
HAEMORRHAGIC STROKE |
15 |
0.0019 |
| 275 |
MEDICATION ERROR |
105 |
0.0019 |
| 276 |
ACCIDENTAL EXPOSURE TO PRODUCT |
194 |
0.0019 |
| 277 |
SKIN SWELLING |
16 |
0.0018 |
| 278 |
SCAB |
21 |
0.0018 |
| 279 |
SKIN IRRITATION |
84 |
0.0018 |
| 280 |
SQUAMOUS CELL CARCINOMA OF SKIN |
11 |
0.0018 |
| 281 |
HYPOTHYROIDISM |
58 |
0.0018 |
| 282 |
DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE |
13 |
0.0018 |
| 283 |
BURNING SENSATION |
127 |
0.0018 |
| 284 |
DIPLOPIA |
47 |
0.0018 |
| 285 |
PRODUCT USE ISSUE |
340 |
0.0018 |
| 286 |
EXPIRED PRODUCT ADMINISTERED |
60 |
0.0018 |
| 287 |
HYPOMAGNESAEMIA |
25 |
0.0018 |
| 288 |
RASH PUSTULAR |
13 |
0.0018 |
| 289 |
INTENTIONAL UNDERDOSE |
13 |
0.0018 |
| 290 |
SWELLING FACE |
115 |
0.0018 |
| 291 |
OPTIC NEURITIS |
16 |
0.0018 |
| 292 |
EYE MOVEMENT DISORDER |
12 |
0.0018 |
| 293 |
SUNBURN |
13 |
0.0017 |
| 294 |
HEART RATE DECREASED |
61 |
0.0017 |
| 295 |
IRON DEFICIENCY ANAEMIA |
16 |
0.0017 |
| 296 |
PRODUCT STORAGE ERROR |
151 |
0.0017 |
| 297 |
VASCULITIS |
20 |
0.0017 |
| 298 |
NASAL CONGESTION |
100 |
0.0017 |
| 299 |
SPINAL COMPRESSION FRACTURE |
14 |
0.0017 |
| 300 |
DIVERTICULUM |
12 |
0.0017 |
| 301 |
MYOSITIS |
15 |
0.0017 |
| 302 |
LETHARGY |
96 |
0.0017 |
| 303 |
MULTIPLE ALLERGIES |
13 |
0.0017 |
| 304 |
ABSCESS LIMB |
7 |
0.0016 |
| 305 |
APPLICATION SITE ERYTHEMA |
43 |
0.0016 |
| 306 |
BLOOD PRESSURE DECREASED |
109 |
0.0016 |
| 307 |
CONDITION AGGRAVATED |
498 |
0.0016 |
| 308 |
ATRIAL FLUTTER |
13 |
0.0016 |
| 309 |
ABNORMAL LOSS OF WEIGHT |
11 |
0.0016 |
| 310 |
RHINORRHOEA |
104 |
0.0016 |
| 311 |
APPLICATION SITE SWELLING |
8 |
0.0016 |
| 312 |
PRODUCT LEAKAGE |
9 |
0.0016 |
| 313 |
HYPOPHAGIA |
41 |
0.0016 |
| 314 |
HYPERAESTHESIA |
13 |
0.0016 |
| 315 |
RIB FRACTURE |
32 |
0.0016 |
| 316 |
SEASONAL ALLERGY |
22 |
0.0016 |
| 317 |
BLOOD UREA INCREASED |
26 |
0.0016 |
| 318 |
INFLAMMATION |
79 |
0.0015 |
| 319 |
PERIPHERAL COLDNESS |
21 |
0.0015 |
| 320 |
RENAL TUBULAR NECROSIS |
15 |
0.0015 |
| 321 |
ATRIAL FIBRILLATION |
148 |
0.0015 |
| 322 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
30 |
0.0015 |
| 323 |
NASAL DISCOMFORT |
12 |
0.0015 |
| 324 |
RENAL CYST |
12 |
0.0015 |
| 325 |
BLADDER DISORDER |
15 |
0.0015 |
| 326 |
DERMATITIS ALLERGIC |
19 |
0.0015 |
| 327 |
CARDIAC PACEMAKER INSERTION |
9 |
0.0015 |
| 328 |
DRUG INTOLERANCE |
145 |
0.0015 |
| 329 |
SOMNOLENCE |
301 |
0.0015 |
| 330 |
EMPHYSEMA |
15 |
0.0015 |
| 331 |
SUBARACHNOID HAEMORRHAGE |
15 |
0.0015 |
| 332 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
13 |
0.0015 |
| 333 |
RESPIRATORY DEPRESSION |
18 |
0.0015 |
| 334 |
UPPER-AIRWAY COUGH SYNDROME |
12 |
0.0015 |
| 335 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
8 |
0.0014 |
| 336 |
FOOT DEFORMITY |
16 |
0.0014 |
| 337 |
STREPTOCOCCAL INFECTION |
8 |
0.0014 |
| 338 |
FORMICATION |
10 |
0.0014 |
| 339 |
TRANSFUSION |
15 |
0.0014 |
| 340 |
MASS |
20 |
0.0014 |
| 341 |
EXOSTOSIS |
13 |
0.0014 |
| 342 |
BALANCE DISORDER |
123 |
0.0014 |
| 343 |
HEMIPARESIS |
24 |
0.0014 |
| 344 |
PELVIC FRACTURE |
11 |
0.0014 |
| 345 |
MENTAL STATUS CHANGES |
39 |
0.0014 |
| 346 |
THERAPY NON-RESPONDER |
63 |
0.0014 |
| 347 |
CARDIAC VALVE DISEASE |
8 |
0.0014 |
| 348 |
SKIN DISCOLOURATION |
64 |
0.0014 |
| 349 |
MIDDLE INSOMNIA |
26 |
0.0014 |
| 350 |
INCOHERENT |
9 |
0.0014 |
| 351 |
PSYCHOLOGICAL TRAUMA |
12 |
0.0014 |
| 352 |
GLOMERULAR FILTRATION RATE DECREASED |
17 |
0.0014 |
| 353 |
PRODUCT DOSE OMISSION |
90 |
0.0014 |
| 354 |
AGEUSIA |
34 |
0.0014 |
| 355 |
APPLICATION SITE PAIN |
30 |
0.0014 |
| 356 |
RASH ERYTHEMATOUS |
65 |
0.0014 |
| 357 |
APPETITE DISORDER |
9 |
0.0014 |
| 358 |
HEAD DISCOMFORT |
24 |
0.0014 |
| 359 |
BLOOD PRESSURE DIASTOLIC DECREASED |
10 |
0.0014 |
| 360 |
RESPIRATORY RATE INCREASED |
12 |
0.0014 |
| 361 |
ATRIOVENTRICULAR BLOCK COMPLETE |
9 |
0.0013 |
| 362 |
TENDERNESS |
14 |
0.0013 |
| 363 |
HYDRONEPHROSIS |
10 |
0.0013 |
| 364 |
PHOTOSENSITIVITY REACTION |
22 |
0.0013 |
| 365 |
PHARYNGEAL SWELLING |
13 |
0.0013 |
| 366 |
HALLUCINATION, VISUAL |
28 |
0.0013 |
| 367 |
RESPIRATORY TRACT CONGESTION |
21 |
0.0013 |
| 368 |
RENAL INJURY |
39 |
0.0013 |
| 369 |
HAEMATOCRIT DECREASED |
26 |
0.0013 |
| 370 |
VERTIGO |
79 |
0.0013 |
| 371 |
PRODUCT DISTRIBUTION ISSUE |
12 |
0.0013 |
| 372 |
BLOOD POTASSIUM INCREASED |
21 |
0.0013 |
| 373 |
SNEEZING |
29 |
0.0013 |
| 374 |
CHOLANGITIS |
8 |
0.0013 |
| 375 |
PRE-EXISTING CONDITION IMPROVED |
8 |
0.0013 |
| 376 |
OESOPHAGITIS |
14 |
0.0013 |
| 377 |
SKIN ULCER |
33 |
0.0013 |
| 378 |
ARTERIOSCLEROSIS |
12 |
0.0013 |
| 379 |
SQUAMOUS CELL CARCINOMA |
12 |
0.0013 |
| 380 |
OSTEOARTHRITIS |
54 |
0.0013 |
| 381 |
CELLULITIS |
64 |
0.0013 |
| 382 |
ORTHOSTATIC HYPOTENSION |
22 |
0.0013 |
| 383 |
ACUTE KIDNEY INJURY |
193 |
0.0013 |
| 384 |
COMA |
60 |
0.0013 |
| 385 |
BLOOD PRESSURE ABNORMAL |
25 |
0.0013 |
| 386 |
IMMUNOSUPPRESSION |
11 |
0.0012 |
| 387 |
BLOOD CALCIUM DECREASED |
14 |
0.0012 |
| 388 |
RHINITIS |
10 |
0.0012 |
| 389 |
FRUSTRATION TOLERANCE DECREASED |
10 |
0.0012 |
| 390 |
CARDIAC FLUTTER |
8 |
0.0012 |
| 391 |
EAR PAIN |
24 |
0.0012 |
| 392 |
DYSPHONIA |
72 |
0.0012 |
| 393 |
URINARY TRACT INFECTION |
209 |
0.0012 |
| 394 |
INTERNAL HAEMORRHAGE |
14 |
0.0012 |
| 395 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
21 |
0.0012 |
| 396 |
FALL |
407 |
0.0012 |
| 397 |
HYPOACUSIS |
52 |
0.0012 |
| 398 |
PULMONARY HYPERTENSION |
25 |
0.0012 |
| 399 |
SKIN LACERATION |
13 |
0.0012 |
| 400 |
UROSEPSIS |
11 |
0.0012 |
| 401 |
DIZZINESS |
593 |
0.0012 |
| 402 |
SENSATION OF FOREIGN BODY |
10 |
0.0012 |
| 403 |
INFUSION SITE ERYTHEMA |
10 |
0.0012 |
| 404 |
FEELING COLD |
33 |
0.0012 |
| 405 |
HYPOTENSION |
237 |
0.0012 |
| 406 |
HAEMORRHOIDS |
23 |
0.0012 |
| 407 |
ISCHAEMIC STROKE |
21 |
0.0012 |
| 408 |
LIP SWELLING |
39 |
0.0012 |
| 409 |
HYPOKINESIA |
17 |
0.0012 |
| 410 |
APATHY |
17 |
0.0012 |
| 411 |
OEDEMA |
63 |
0.0012 |
| 412 |
RESPIRATION ABNORMAL |
8 |
0.0012 |
| 413 |
JOINT EFFUSION |
8 |
0.0012 |
| 414 |
SPUTUM DISCOLOURED |
11 |
0.0012 |
| 415 |
BLOOD PRESSURE INCREASED |
177 |
0.0012 |
| 416 |
HALLUCINATION |
87 |
0.0012 |
| 417 |
RED BLOOD CELL COUNT DECREASED |
33 |
0.0012 |
| 418 |
HEART RATE IRREGULAR |
26 |
0.0011 |
| 419 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
60 |
0.0011 |
| 420 |
DEAFNESS |
30 |
0.0011 |
| 421 |
EXTRASYSTOLES |
8 |
0.0011 |
| 422 |
DYSPNOEA EXERTIONAL |
43 |
0.0011 |
| 423 |
FULL BLOOD COUNT DECREASED |
23 |
0.0011 |
| 424 |
PULMONARY MASS |
17 |
0.0011 |
| 425 |
BLISTER |
64 |
0.0011 |
| 426 |
PRODUCT DOSE OMISSION ISSUE |
335 |
0.0011 |
| 427 |
GROIN PAIN |
10 |
0.0011 |
| 428 |
SPINAL OSTEOARTHRITIS |
10 |
0.0011 |
| 429 |
SINUS BRADYCARDIA |
11 |
0.0011 |
| 430 |
JOINT DISLOCATION |
12 |
0.0011 |
| 431 |
DUODENAL ULCER |
8 |
0.0011 |
| 432 |
TINNITUS |
52 |
0.0011 |
| 433 |
DISCOMFORT |
69 |
0.0011 |
| 434 |
VITAMIN D DEFICIENCY |
11 |
0.0011 |
| 435 |
JOINT INJURY |
24 |
0.0011 |
| 436 |
ECONOMIC PROBLEM |
17 |
0.0011 |
| 437 |
FLUID RETENTION |
57 |
0.0011 |
| 438 |
LOCALISED INFECTION |
27 |
0.0011 |
| 439 |
RENAL FAILURE |
148 |
0.0011 |
| 440 |
HOT FLUSH |
84 |
0.0011 |
| 441 |
SKIN EXFOLIATION |
94 |
0.0011 |
| 442 |
DEMENTIA |
31 |
0.0011 |
| 443 |
BACK DISORDER |
18 |
0.0011 |
| 444 |
MUSCLE ATROPHY |
14 |
0.0011 |
| 445 |
OSTEOMYELITIS |
20 |
0.0011 |
| 446 |
UPPER LIMB FRACTURE |
22 |
0.0011 |
| 447 |
PERIPHERAL SWELLING |
170 |
0.0011 |
| 448 |
POST PROCEDURAL COMPLICATION |
21 |
0.0011 |
| 449 |
PRODUCT QUALITY ISSUE |
148 |
0.0011 |
| 450 |
BASAL CELL CARCINOMA |
17 |
0.0011 |
| 451 |
BRAIN FOG |
17 |
0.0011 |
| 452 |
WRIST FRACTURE |
13 |
0.0011 |
| 453 |
HIATUS HERNIA |
14 |
0.0011 |
| 454 |
HYPOXIA |
38 |
0.0011 |
| 455 |
EAR DISCOMFORT |
11 |
0.0011 |
| 456 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
193 |
0.0011 |
| 457 |
SCIATICA |
17 |
0.0011 |
| 458 |
HAEMATEMESIS |
27 |
0.0011 |
| 459 |
THERAPY INTERRUPTED |
76 |
0.0011 |
| 460 |
HYPOAESTHESIA ORAL |
16 |
0.0011 |
| 461 |
SINUS DISORDER |
21 |
0.0011 |
| 462 |
POLLAKIURIA |
44 |
0.0011 |
| 463 |
BLOOD URINE PRESENT |
20 |
0.0011 |
| 464 |
INTERVERTEBRAL DISC PROTRUSION |
23 |
0.0011 |
| 465 |
INTENTIONAL PRODUCT MISUSE |
92 |
0.0010 |
| 466 |
MICTURITION URGENCY |
12 |
0.0010 |
| 467 |
DYSGEUSIA |
78 |
0.0010 |
| 468 |
SKIN HYPERPIGMENTATION |
9 |
0.0010 |
| 469 |
ADVERSE DRUG REACTION |
94 |
0.0010 |
| 470 |
HYPERSOMNIA |
30 |
0.0010 |
| 471 |
INSURANCE ISSUE |
16 |
0.0010 |
| 472 |
BOWEL MOVEMENT IRREGULARITY |
8 |
0.0010 |
| 473 |
HAEMOGLOBIN DECREASED |
107 |
0.0010 |
| 474 |
PARAESTHESIA ORAL |
15 |
0.0010 |
| 475 |
ATRIOVENTRICULAR BLOCK |
8 |
0.0010 |
| 476 |
CONFUSIONAL STATE |
167 |
0.0010 |
| 477 |
LIMB INJURY |
28 |
0.0010 |
| 478 |
DELUSION |
16 |
0.0010 |
| 479 |
HYPONATRAEMIA |
58 |
0.0010 |
| 480 |
ORAL PAIN |
23 |
0.0010 |
| 481 |
BLOOD PRESSURE SYSTOLIC INCREASED |
20 |
0.0010 |
| 482 |
THROAT IRRITATION |
46 |
0.0010 |
| 483 |
PAIN IN JAW |
29 |
0.0010 |
| 484 |
DECREASED ACTIVITY |
11 |
0.0010 |
| 485 |
INTENTIONAL DOSE OMISSION |
29 |
0.0010 |
| 486 |
THERAPY CHANGE |
10 |
0.0010 |
| 487 |
HYPERGLYCAEMIA |
37 |
0.0010 |
| 488 |
ATAXIA |
12 |
0.0010 |
| 489 |
SYNCOPE |
101 |
0.0010 |
| 490 |
UNRESPONSIVE TO STIMULI |
26 |
0.0010 |
| 491 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
29 |
0.0010 |
| 492 |
GINGIVAL PAIN |
8 |
0.0010 |
| 493 |
GASTROINTESTINAL HAEMORRHAGE |
84 |
0.0010 |
| 494 |
GOUT |
18 |
0.0010 |
| 495 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
55 |
0.0010 |
| 496 |
COUGH |
281 |
0.0010 |
| 497 |
ASTHENIA |
376 |
0.0010 |
| 498 |
OROPHARYNGEAL DISCOMFORT |
9 |
0.0010 |
| 499 |
SLEEP APNOEA SYNDROME |
19 |
0.0010 |
| 500 |
DRUG INEFFECTIVE |
1311 |
0.0010 |
| 501 |
LIP DRY |
9 |
0.0010 |
| 502 |
MUSCULOSKELETAL DISCOMFORT |
17 |
0.0010 |
| 503 |
SINUSITIS |
101 |
0.0010 |
| 504 |
MUSCULAR WEAKNESS |
112 |
0.0010 |
| 505 |
DECUBITUS ULCER |
8 |
0.0010 |
| 506 |
URINARY INCONTINENCE |
29 |
0.0010 |
| 507 |
NERVE COMPRESSION |
9 |
0.0010 |
| 508 |
IMPAIRED QUALITY OF LIFE |
14 |
0.0010 |
| 509 |
JOINT RANGE OF MOTION DECREASED |
13 |
0.0010 |
| 510 |
PULMONARY ARTERIAL HYPERTENSION |
14 |
0.0010 |
| 511 |
HIP FRACTURE |
31 |
0.0010 |
| 512 |
SKIN DISORDER |
32 |
0.0010 |
| 513 |
HYPERTENSION |
203 |
0.0010 |
| 514 |
LACERATION |
9 |
0.0010 |
| 515 |
WEIGHT FLUCTUATION |
10 |
0.0010 |
| 516 |
INCORRECT DOSE ADMINISTERED |
218 |
0.0010 |
| 517 |
MELAENA |
21 |
0.0010 |
| 518 |
PRODUCT DOSE OMISSION IN ERROR |
27 |
0.0010 |
| 519 |
EPISTAXIS |
71 |
0.0009 |
| 520 |
ASTHMA |
107 |
0.0009 |
| 521 |
DRY SKIN |
126 |
0.0009 |
| 522 |
OXYGEN SATURATION DECREASED |
53 |
0.0009 |
| 523 |
CLOSTRIDIUM DIFFICILE COLITIS |
10 |
0.0009 |
| 524 |
HYPERKALAEMIA |
33 |
0.0009 |
| 525 |
EXTRA DOSE ADMINISTERED |
38 |
0.0009 |
| 526 |
ENCEPHALOPATHY |
23 |
0.0009 |
| 527 |
ROTATOR CUFF SYNDROME |
12 |
0.0009 |
| 528 |
WOUND |
26 |
0.0009 |
| 529 |
FATIGUE |
722 |
0.0009 |
| 530 |
MUSCLE STRAIN |
8 |
0.0009 |
| 531 |
DYSURIA |
34 |
0.0009 |
| 532 |
RENAL DISORDER |
43 |
0.0009 |
| 533 |
PALPITATIONS |
108 |
0.0009 |
| 534 |
PULMONARY THROMBOSIS |
10 |
0.0009 |
| 535 |
THERAPEUTIC RESPONSE UNEXPECTED |
41 |
0.0009 |
| 536 |
INCORRECT PRODUCT STORAGE |
12 |
0.0009 |
| 537 |
ANAEMIA |
174 |
0.0009 |
| 538 |
CYSTITIS |
29 |
0.0009 |
| 539 |
PRURITUS |
349 |
0.0009 |
| 540 |
HYPOGLYCAEMIA |
44 |
0.0009 |
| 541 |
CARDIOGENIC SHOCK |
13 |
0.0009 |
| 542 |
SURGERY |
53 |
0.0009 |
| 543 |
CONSTIPATION |
197 |
0.0009 |
| 544 |
PNEUMONIA |
292 |
0.0009 |
| 545 |
NIGHT SWEATS |
29 |
0.0009 |
| 546 |
HAIR TEXTURE ABNORMAL |
12 |
0.0009 |
| 547 |
TREATMENT NONCOMPLIANCE |
49 |
0.0009 |
| 548 |
GASTROOESOPHAGEAL REFLUX DISEASE |
72 |
0.0009 |
| 549 |
NEPHROLITHIASIS |
41 |
0.0009 |
| 550 |
FLUID OVERLOAD |
13 |
0.0009 |
| 551 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
15 |
0.0009 |
| 552 |
RETCHING |
19 |
0.0009 |
| 553 |
HEADACHE |
558 |
0.0009 |
| 554 |
LOSS OF CONSCIOUSNESS |
114 |
0.0009 |
| 555 |
ANAL INCONTINENCE |
8 |
0.0009 |
| 556 |
TRANSIENT ISCHAEMIC ATTACK |
30 |
0.0009 |
| 557 |
FREQUENT BOWEL MOVEMENTS |
24 |
0.0009 |
| 558 |
BLOOD CREATININE INCREASED |
58 |
0.0009 |
| 559 |
SLUGGISHNESS |
9 |
0.0009 |
| 560 |
PRODUCTIVE COUGH |
42 |
0.0009 |
| 561 |
PRODUCT AVAILABILITY ISSUE |
20 |
0.0009 |
| 562 |
SKIN HAEMORRHAGE |
13 |
0.0009 |
| 563 |
INTERNATIONAL NORMALISED RATIO INCREASED |
25 |
0.0009 |
| 564 |
NEUROPATHY PERIPHERAL |
83 |
0.0009 |
| 565 |
OEDEMA PERIPHERAL |
106 |
0.0009 |
| 566 |
DIVERTICULITIS |
24 |
0.0009 |
| 567 |
DECREASED APPETITE |
201 |
0.0009 |
| 568 |
EAR INFECTION |
23 |
0.0009 |
| 569 |
ORAL DISCOMFORT |
12 |
0.0009 |
| 570 |
MADAROSIS |
10 |
0.0009 |
| 571 |
HAEMOPTYSIS |
24 |
0.0009 |
| 572 |
NEPHROPATHY |
8 |
0.0009 |
| 573 |
DYSSTASIA |
25 |
0.0009 |
| 574 |
FLANK PAIN |
8 |
0.0009 |
| 575 |
SCRATCH |
9 |
0.0009 |
| 576 |
INCONTINENCE |
9 |
0.0009 |
| 577 |
BLOOD SODIUM DECREASED |
16 |
0.0008 |
| 578 |
CARDIAC FAILURE CONGESTIVE |
68 |
0.0008 |
| 579 |
FLATULENCE |
48 |
0.0008 |
| 580 |
GAIT DISTURBANCE |
162 |
0.0008 |
| 581 |
HYPOCALCAEMIA |
16 |
0.0008 |
| 582 |
SPINAL DISORDER |
8 |
0.0008 |
| 583 |
INTENTIONAL PRODUCT USE ISSUE |
74 |
0.0008 |
| 584 |
PNEUMONITIS |
23 |
0.0008 |
| 585 |
BACTERAEMIA |
10 |
0.0008 |
| 586 |
CONTUSION |
81 |
0.0008 |
| 587 |
PNEUMONIA ASPIRATION |
21 |
0.0008 |
| 588 |
DEHYDRATION |
112 |
0.0008 |
| 589 |
ARTHRITIS |
66 |
0.0008 |
| 590 |
SUBDURAL HAEMATOMA |
12 |
0.0008 |
| 591 |
HYPERLIPIDAEMIA |
10 |
0.0008 |
| 592 |
SUPRAVENTRICULAR TACHYCARDIA |
8 |
0.0008 |
| 593 |
ATELECTASIS |
8 |
0.0008 |
| 594 |
CYANOSIS |
13 |
0.0008 |
| 595 |
PRODUCT DISPENSING ERROR |
18 |
0.0008 |
| 596 |
GASTROENTERITIS |
12 |
0.0008 |
| 597 |
AUTOIMMUNE DISORDER |
8 |
0.0008 |
| 598 |
ORAL HERPES |
16 |
0.0008 |
| 599 |
OFF LABEL USE |
716 |
0.0008 |
| 600 |
DRUG EFFECT DECREASED |
44 |
0.0008 |
| 601 |
ABSCESS |
13 |
0.0008 |
| 602 |
CARDIOMEGALY |
10 |
0.0008 |
| 603 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
39 |
0.0008 |
| 604 |
TACHYPNOEA |
11 |
0.0008 |
| 605 |
CARDIAC MURMUR |
7 |
0.0008 |
| 606 |
GAIT INABILITY |
27 |
0.0008 |
| 607 |
UNEVALUABLE EVENT |
61 |
0.0008 |
| 608 |
CYST |
10 |
0.0008 |
| 609 |
BACTERIAL INFECTION |
15 |
0.0008 |
| 610 |
ARRHYTHMIA |
38 |
0.0008 |
| 611 |
RESPIRATORY DISORDER |
24 |
0.0008 |
| 612 |
CORONARY ARTERY OCCLUSION |
11 |
0.0008 |
| 613 |
PRODUCT SUBSTITUTION ISSUE |
46 |
0.0008 |
| 614 |
BLOOD POTASSIUM DECREASED |
24 |
0.0008 |
| 615 |
HAEMATOCHEZIA |
44 |
0.0008 |
| 616 |
DYSARTHRIA |
30 |
0.0008 |
| 617 |
IMPAIRED HEALING |
26 |
0.0008 |
| 618 |
CHEST DISCOMFORT |
81 |
0.0008 |
| 619 |
DYSPNOEA |
447 |
0.0008 |
| 620 |
TASTE DISORDER |
16 |
0.0008 |
| 621 |
PRURITUS GENERALISED |
17 |
0.0008 |
| 622 |
BLOOD TEST ABNORMAL |
11 |
0.0008 |
| 623 |
PULMONARY OEDEMA |
35 |
0.0008 |
| 624 |
NEURALGIA |
19 |
0.0008 |
| 625 |
PRODUCT PRESCRIBING ISSUE |
17 |
0.0008 |
| 626 |
NIGHTMARE |
27 |
0.0008 |
| 627 |
SWELLING |
73 |
0.0008 |
| 628 |
URINARY RETENTION |
26 |
0.0008 |
| 629 |
CLOSTRIDIUM DIFFICILE INFECTION |
17 |
0.0008 |
| 630 |
LYMPHOPENIA |
11 |
0.0008 |
| 631 |
LIMB DISCOMFORT |
24 |
0.0008 |
| 632 |
PARAESTHESIA |
122 |
0.0008 |
| 633 |
TOOTHACHE |
14 |
0.0008 |
| 634 |
HAEMATOMA |
20 |
0.0008 |
| 635 |
VENTRICULAR EXTRASYSTOLES |
8 |
0.0008 |
| 636 |
SKIN FISSURES |
15 |
0.0008 |
| 637 |
PLATELET COUNT INCREASED |
10 |
0.0008 |
| 638 |
NODULE |
10 |
0.0008 |
| 639 |
SLEEP DISORDER |
54 |
0.0008 |
| 640 |
PAIN IN EXTREMITY |
225 |
0.0008 |
| 641 |
WEIGHT DECREASED |
213 |
0.0008 |
| 642 |
INFLUENZA |
85 |
0.0008 |
| 643 |
RESPIRATORY DISTRESS |
21 |
0.0008 |
| 644 |
GASTRITIS |
20 |
0.0008 |
| 645 |
ANOSMIA |
11 |
0.0008 |
| 646 |
HAEMATURIA |
26 |
0.0008 |
| 647 |
TOOTH INFECTION |
10 |
0.0008 |
| 648 |
BLOOD IRON DECREASED |
9 |
0.0008 |
| 649 |
HEAD INJURY |
24 |
0.0008 |
| 650 |
RENAL PAIN |
8 |
0.0008 |
| 651 |
EPILEPSY |
23 |
0.0008 |
| 652 |
PRESCRIBED UNDERDOSE |
15 |
0.0008 |
| 653 |
ACNE |
57 |
0.0008 |
| 654 |
POLYNEUROPATHY |
9 |
0.0008 |
| 655 |
DIARRHOEA |
485 |
0.0008 |
| 656 |
BLOOD CHOLESTEROL INCREASED |
35 |
0.0008 |
| 657 |
METABOLIC ACIDOSIS |
24 |
0.0007 |
| 658 |
FUNGAL INFECTION |
25 |
0.0007 |
| 659 |
SENSORY DISTURBANCE |
12 |
0.0007 |
| 660 |
RECTAL HAEMORRHAGE |
32 |
0.0007 |
| 661 |
DEVICE USE ISSUE |
13 |
0.0007 |
| 662 |
BRONCHITIS |
55 |
0.0007 |
| 663 |
DYSPEPSIA |
73 |
0.0007 |
| 664 |
RASH |
323 |
0.0007 |
| 665 |
DEPRESSED MOOD |
39 |
0.0007 |
| 666 |
SWOLLEN TONGUE |
23 |
0.0007 |
| 667 |
PROTEINURIA |
14 |
0.0007 |
| 668 |
HAEMORRHAGE INTRACRANIAL |
11 |
0.0007 |
| 669 |
MEMORY IMPAIRMENT |
101 |
0.0007 |
| 670 |
BACK PAIN |
170 |
0.0007 |
| 671 |
SMALL INTESTINAL OBSTRUCTION |
9 |
0.0007 |
| 672 |
RENAL FAILURE ACUTE |
31 |
0.0007 |
| 673 |
WOUND INFECTION |
8 |
0.0007 |
| 674 |
NERVOUSNESS |
38 |
0.0007 |
| 675 |
GENERALISED OEDEMA |
9 |
0.0007 |
| 676 |
HEART RATE INCREASED |
72 |
0.0007 |
| 677 |
CONTRAINDICATED PRODUCT ADMINISTERED |
22 |
0.0007 |
| 678 |
THERAPEUTIC RESPONSE DECREASED |
44 |
0.0007 |
| 679 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
147 |
0.0007 |
| 680 |
HERNIA |
14 |
0.0007 |
| 681 |
DRUG DOSE OMISSION |
119 |
0.0007 |
| 682 |
RASH PRURITIC |
39 |
0.0007 |
| 683 |
TOOTH DISORDER |
16 |
0.0007 |
| 684 |
HYPERTENSIVE CRISIS |
8 |
0.0007 |
| 685 |
SECRETION DISCHARGE |
9 |
0.0007 |
| 686 |
APHONIA |
10 |
0.0007 |
| 687 |
NECK PAIN |
40 |
0.0007 |
| 688 |
HERPES ZOSTER |
41 |
0.0007 |
| 689 |
NEPHROPATHY TOXIC |
8 |
0.0007 |
| 690 |
KNEE ARTHROPLASTY |
15 |
0.0007 |
| 691 |
ACUTE MYOCARDIAL INFARCTION |
21 |
0.0007 |
| 692 |
MOUTH ULCERATION |
15 |
0.0007 |
| 693 |
MUSCULOSKELETAL CHEST PAIN |
11 |
0.0007 |
| 694 |
ANKLE FRACTURE |
11 |
0.0007 |
| 695 |
PRODUCT COMPLAINT |
18 |
0.0007 |
| 696 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
13 |
0.0007 |
| 697 |
HEPATOCELLULAR INJURY |
10 |
0.0007 |
| 698 |
THROAT TIGHTNESS |
19 |
0.0007 |
| 699 |
OROPHARYNGEAL PAIN |
65 |
0.0007 |
| 700 |
INSOMNIA |
187 |
0.0007 |
| 701 |
BRAIN INJURY |
7 |
0.0007 |
| 702 |
POOR QUALITY SLEEP |
15 |
0.0007 |
| 703 |
DIABETES MELLITUS |
53 |
0.0007 |
| 704 |
HYPOAESTHESIA |
104 |
0.0007 |
| 705 |
LUNG DISORDER |
34 |
0.0007 |
| 706 |
TUBULOINTERSTITIAL NEPHRITIS |
13 |
0.0007 |
| 707 |
WHEEZING |
41 |
0.0007 |
| 708 |
DRUG EFFECT INCOMPLETE |
25 |
0.0007 |
| 709 |
BLOOD GLUCOSE DECREASED |
33 |
0.0007 |
| 710 |
FRACTURE |
13 |
0.0007 |
| 711 |
DYSPHAGIA |
65 |
0.0007 |
| 712 |
FEELING JITTERY |
13 |
0.0007 |
| 713 |
DIABETES MELLITUS INADEQUATE CONTROL |
12 |
0.0007 |
| 714 |
ACUTE RESPIRATORY FAILURE |
13 |
0.0007 |
| 715 |
GALLBLADDER DISORDER |
12 |
0.0007 |
| 716 |
MALIGNANT MELANOMA |
9 |
0.0007 |
| 717 |
PRODUCT PRESCRIBING ERROR |
16 |
0.0007 |
| 718 |
RHEUMATOID ARTHRITIS |
76 |
0.0007 |
| 719 |
TREMOR |
111 |
0.0007 |
| 720 |
ABDOMINAL DISCOMFORT |
112 |
0.0007 |
| 721 |
GASTROENTERITIS VIRAL |
12 |
0.0007 |
| 722 |
ERECTILE DYSFUNCTION |
17 |
0.0007 |
| 723 |
ABDOMINAL PAIN |
154 |
0.0007 |
| 724 |
CORONARY ARTERY DISEASE |
20 |
0.0007 |
| 725 |
ADRENAL INSUFFICIENCY |
8 |
0.0007 |
| 726 |
GINGIVAL BLEEDING |
9 |
0.0007 |
| 727 |
RESPIRATORY FAILURE |
48 |
0.0007 |
| 728 |
RENAL IMPAIRMENT |
55 |
0.0007 |
| 729 |
DRUG DISPENSING ERROR |
10 |
0.0007 |
| 730 |
SPINAL OPERATION |
8 |
0.0006 |
| 731 |
MUSCULOSKELETAL PAIN |
34 |
0.0006 |
| 732 |
PERICARDIAL EFFUSION |
15 |
0.0006 |
| 733 |
BONE PAIN |
38 |
0.0006 |
| 734 |
CHILLS |
76 |
0.0006 |
| 735 |
THROMBOSIS |
52 |
0.0006 |
| 736 |
FAECES DISCOLOURED |
14 |
0.0006 |
| 737 |
AMNESIA |
42 |
0.0006 |
| 738 |
PRODUCT PHYSICAL ISSUE |
13 |
0.0006 |
| 739 |
BIPOLAR DISORDER |
7 |
0.0006 |
| 740 |
ABDOMINAL PAIN UPPER |
132 |
0.0006 |
| 741 |
MALAISE |
281 |
0.0006 |
| 742 |
HEPATIC CIRRHOSIS |
12 |
0.0006 |
| 743 |
CEREBROVASCULAR ACCIDENT |
108 |
0.0006 |
| 744 |
STAPHYLOCOCCAL INFECTION |
21 |
0.0006 |
| 745 |
DEVICE DEFECTIVE |
11 |
0.0006 |
| 746 |
DEPRESSION |
144 |
0.0006 |
| 747 |
OSTEOPOROSIS |
26 |
0.0006 |
| 748 |
CHEST PAIN |
117 |
0.0006 |
| 749 |
DEEP VEIN THROMBOSIS |
41 |
0.0006 |
| 750 |
CARDIAC DISORDER |
59 |
0.0006 |
| 751 |
ARTHROPATHY |
35 |
0.0006 |
| 752 |
ACCIDENTAL OVERDOSE |
23 |
0.0006 |
| 753 |
ULCER |
10 |
0.0006 |
| 754 |
ALOPECIA |
123 |
0.0006 |
| 755 |
COLD SWEAT |
11 |
0.0006 |
| 756 |
ROAD TRAFFIC ACCIDENT |
26 |
0.0006 |
| 757 |
JOINT SWELLING |
75 |
0.0006 |
| 758 |
COVID-19 |
109 |
0.0006 |
| 759 |
NASOPHARYNGITIS |
114 |
0.0006 |
| 760 |
EXPOSURE VIA SKIN CONTACT |
16 |
0.0006 |
| 761 |
PRESYNCOPE |
15 |
0.0006 |
| 762 |
PLASMA CELL MYELOMA |
24 |
0.0006 |
| 763 |
RESPIRATORY TRACT INFECTION |
16 |
0.0006 |
| 764 |
FEELING ABNORMAL |
147 |
0.0006 |
| 765 |
GASTRIC DISORDER |
21 |
0.0006 |
| 766 |
ELECTROCARDIOGRAM QT PROLONGED |
22 |
0.0006 |
| 767 |
SPEECH DISORDER |
32 |
0.0006 |
| 768 |
BLOOD GLUCOSE INCREASED |
115 |
0.0006 |
| 769 |
LABORATORY TEST ABNORMAL |
18 |
0.0006 |
| 770 |
CARDIOMYOPATHY |
9 |
0.0006 |
| 771 |
PLEURAL EFFUSION |
37 |
0.0006 |
| 772 |
ADVERSE EVENT |
56 |
0.0006 |
| 773 |
DISABILITY |
12 |
0.0006 |
| 774 |
HYPOKALAEMIA |
28 |
0.0006 |
| 775 |
UNDERDOSE |
44 |
0.0006 |
| 776 |
PRODUCT USE IN UNAPPROVED INDICATION |
149 |
0.0006 |
| 777 |
RESTLESSNESS |
22 |
0.0006 |
| 778 |
SPINAL FRACTURE |
12 |
0.0006 |
| 779 |
ARTHRALGIA |
249 |
0.0006 |
| 780 |
CARDIAC FAILURE |
48 |
0.0006 |
| 781 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
15 |
0.0006 |
| 782 |
STOMATITIS |
36 |
0.0006 |
| 783 |
OSTEOPENIA |
9 |
0.0006 |
| 784 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
20 |
0.0006 |
| 785 |
SINUS CONGESTION |
8 |
0.0006 |
| 786 |
SEPSIS |
66 |
0.0006 |
| 787 |
MOVEMENT DISORDER |
19 |
0.0006 |
| 788 |
NO ADVERSE EVENT |
107 |
0.0006 |
| 789 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
42 |
0.0006 |
| 790 |
INFECTION |
85 |
0.0006 |
| 791 |
DRUG ADMINISTRATION ERROR |
18 |
0.0006 |
| 792 |
WEIGHT INCREASED |
131 |
0.0006 |
| 793 |
THYROID DISORDER |
9 |
0.0006 |
| 794 |
MUSCLE SPASMS |
107 |
0.0006 |
| 795 |
GLOSSODYNIA |
13 |
0.0006 |
| 796 |
RASH GENERALISED |
15 |
0.0006 |
| 797 |
GASTRIC ULCER |
11 |
0.0006 |
| 798 |
BURSITIS |
7 |
0.0006 |
| 799 |
THERAPY PARTIAL RESPONDER |
9 |
0.0006 |
| 800 |
PAIN |
354 |
0.0006 |
| 801 |
COORDINATION ABNORMAL |
8 |
0.0006 |
| 802 |
LOCAL SWELLING |
10 |
0.0006 |
| 803 |
APPLICATION SITE PRURITUS |
13 |
0.0006 |
| 804 |
ERUCTATION |
11 |
0.0006 |
| 805 |
DEVICE OCCLUSION |
8 |
0.0006 |
| 806 |
ABASIA |
14 |
0.0006 |
| 807 |
DISEASE PROGRESSION |
67 |
0.0006 |
| 808 |
DYSKINESIA |
23 |
0.0006 |
| 809 |
LYMPHOCYTE COUNT DECREASED |
10 |
0.0006 |
| 810 |
EATING DISORDER |
12 |
0.0006 |
| 811 |
APHASIA |
17 |
0.0006 |
| 812 |
BRONCHOSPASM |
8 |
0.0006 |
| 813 |
DISORIENTATION |
22 |
0.0006 |
| 814 |
DRUG INTERACTION |
88 |
0.0006 |
| 815 |
COLITIS |
21 |
0.0006 |
| 816 |
GENERAL PHYSICAL HEALTH DETERIORATION |
64 |
0.0006 |
| 817 |
RESTLESS LEGS SYNDROME |
10 |
0.0005 |
| 818 |
FEMUR FRACTURE |
17 |
0.0005 |
| 819 |
IRRITABILITY |
33 |
0.0005 |
| 820 |
BONE DISORDER |
10 |
0.0005 |
| 821 |
WHITE BLOOD CELL COUNT INCREASED |
21 |
0.0005 |
| 822 |
MYALGIA |
93 |
0.0005 |
| 823 |
ASPARTATE AMINOTRANSFERASE INCREASED |
29 |
0.0005 |
| 824 |
THROMBOCYTOPENIA |
61 |
0.0005 |
| 825 |
EMOTIONAL DISTRESS |
66 |
0.0005 |
| 826 |
NAUSEA |
431 |
0.0005 |
| 827 |
PLATELET COUNT DECREASED |
58 |
0.0005 |
| 828 |
PYREXIA |
187 |
0.0005 |
| 829 |
COAGULOPATHY |
9 |
0.0005 |
| 830 |
DRUG EFFECT LESS THAN EXPECTED |
8 |
0.0005 |
| 831 |
RASH MACULO-PAPULAR |
12 |
0.0005 |
| 832 |
BODY TEMPERATURE INCREASED |
11 |
0.0005 |
| 833 |
COLON CANCER |
8 |
0.0005 |
| 834 |
PANCYTOPENIA |
30 |
0.0005 |
| 835 |
MENTAL IMPAIRMENT |
13 |
0.0005 |
| 836 |
GASTROINTESTINAL DISORDER |
48 |
0.0005 |
| 837 |
TACHYCARDIA |
47 |
0.0005 |
| 838 |
SEPTIC SHOCK |
23 |
0.0005 |
| 839 |
ABDOMINAL DISTENSION |
55 |
0.0005 |
| 840 |
WHITE BLOOD CELL COUNT DECREASED |
57 |
0.0005 |
| 841 |
DEVICE FAILURE |
8 |
0.0005 |
| 842 |
MUSCULOSKELETAL DISORDER |
10 |
0.0005 |
| 843 |
MIGRAINE |
50 |
0.0005 |
| 844 |
ANGINA PECTORIS |
15 |
0.0005 |
| 845 |
MUSCLE TWITCHING |
12 |
0.0005 |
| 846 |
DRUG PRESCRIBING ERROR |
10 |
0.0005 |
| 847 |
HYPERHIDROSIS |
67 |
0.0005 |
| 848 |
ECZEMA |
27 |
0.0005 |
| 849 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
23 |
0.0005 |
| 850 |
CHOKING |
10 |
0.0005 |
| 851 |
SKIN CANCER |
11 |
0.0005 |
| 852 |
BONE DENSITY DECREASED |
16 |
0.0005 |
| 853 |
KIDNEY INFECTION |
10 |
0.0005 |
| 854 |
ANXIETY |
145 |
0.0005 |
| 855 |
HAEMORRHAGE |
53 |
0.0005 |
| 856 |
THERAPY CESSATION |
26 |
0.0005 |
| 857 |
PNEUMOTHORAX |
8 |
0.0005 |
| 858 |
HOSPITALISATION |
77 |
0.0005 |
| 859 |
MOBILITY DECREASED |
36 |
0.0005 |
| 860 |
CYTOKINE RELEASE SYNDROME |
10 |
0.0005 |
| 861 |
DEATH |
429 |
0.0005 |
| 862 |
UPPER RESPIRATORY TRACT INFECTION |
23 |
0.0005 |
| 863 |
LACTIC ACIDOSIS |
16 |
0.0005 |
| 864 |
TOXICITY TO VARIOUS AGENTS |
83 |
0.0005 |
| 865 |
AGITATION |
36 |
0.0005 |
| 866 |
VOMITING |
230 |
0.0005 |
| 867 |
CARDIAC ARREST |
40 |
0.0005 |
| 868 |
FEAR |
13 |
0.0005 |
| 869 |
JAUNDICE |
13 |
0.0005 |
| 870 |
URTICARIA |
80 |
0.0005 |
| 871 |
CEREBRAL HAEMORRHAGE |
17 |
0.0005 |
| 872 |
CANDIDA INFECTION |
8 |
0.0005 |
| 873 |
PULMONARY EMBOLISM |
45 |
0.0005 |
| 874 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
8 |
0.0005 |
| 875 |
ABNORMAL DREAMS |
13 |
0.0005 |
| 876 |
CHOLESTASIS |
9 |
0.0005 |
| 877 |
IMPAIRED WORK ABILITY |
10 |
0.0005 |
| 878 |
SCAR |
8 |
0.0005 |
| 879 |
NEUTROPHIL COUNT DECREASED |
19 |
0.0005 |
| 880 |
BONE LOSS |
7 |
0.0005 |
| 881 |
ALTERED STATE OF CONSCIOUSNESS |
10 |
0.0005 |
| 882 |
SEIZURE |
53 |
0.0005 |
| 883 |
CHOLELITHIASIS |
15 |
0.0005 |
| 884 |
ANHEDONIA |
12 |
0.0005 |
| 885 |
MUSCULOSKELETAL STIFFNESS |
40 |
0.0005 |
| 886 |
PANCREATITIS |
24 |
0.0005 |
| 887 |
FIBROMYALGIA |
11 |
0.0005 |
| 888 |
STEVENS-JOHNSON SYNDROME |
10 |
0.0004 |
| 889 |
FEEDING DISORDER |
9 |
0.0004 |
| 890 |
MYOCARDIAL INFARCTION |
77 |
0.0004 |
| 891 |
MOOD ALTERED |
12 |
0.0004 |
| 892 |
MENTAL DISORDER |
19 |
0.0004 |
| 893 |
PROCEDURAL PAIN |
12 |
0.0004 |
| 894 |
THINKING ABNORMAL |
8 |
0.0004 |
| 895 |
ILLNESS |
44 |
0.0004 |
| 896 |
INCORRECT DRUG ADMINISTRATION DURATION |
12 |
0.0004 |
| 897 |
FOOT FRACTURE |
8 |
0.0004 |
| 898 |
LOWER LIMB FRACTURE |
8 |
0.0004 |
| 899 |
DIABETIC KETOACIDOSIS |
10 |
0.0004 |
| 900 |
ANAPHYLACTIC REACTION |
23 |
0.0004 |
| 901 |
TYPE 2 DIABETES MELLITUS |
14 |
0.0004 |
| 902 |
LIVER FUNCTION TEST ABNORMAL |
12 |
0.0004 |
| 903 |
HEPATIC ENZYME INCREASED |
28 |
0.0004 |
| 904 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
12 |
0.0004 |
| 905 |
CHROMATURIA |
9 |
0.0004 |
| 906 |
LYMPHADENOPATHY |
14 |
0.0004 |
| 907 |
INJURY ASSOCIATED WITH DEVICE |
8 |
0.0004 |
| 908 |
SHOCK |
9 |
0.0004 |
| 909 |
DEVICE ISSUE |
35 |
0.0004 |
| 910 |
PRODUCT PREPARATION ERROR |
8 |
0.0004 |
| 911 |
LUNG NEOPLASM MALIGNANT |
16 |
0.0004 |
| 912 |
EMOTIONAL DISORDER |
12 |
0.0004 |
| 913 |
INFLUENZA LIKE ILLNESS |
32 |
0.0004 |
| 914 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
9 |
0.0004 |
| 915 |
CRYING |
14 |
0.0004 |
| 916 |
C-REACTIVE PROTEIN INCREASED |
14 |
0.0004 |
| 917 |
ANGER |
13 |
0.0004 |
| 918 |
JOINT STIFFNESS |
10 |
0.0004 |
| 919 |
INTERSTITIAL LUNG DISEASE |
18 |
0.0004 |
| 920 |
INTESTINAL OBSTRUCTION |
14 |
0.0004 |
| 921 |
DISTURBANCE IN ATTENTION |
20 |
0.0004 |
| 922 |
DEVICE DELIVERY SYSTEM ISSUE |
10 |
0.0004 |
| 923 |
SKIN LESION |
10 |
0.0004 |
| 924 |
INJECTION SITE HAEMORRHAGE |
29 |
0.0004 |
| 925 |
RESPIRATORY ARREST |
10 |
0.0004 |
| 926 |
THERAPEUTIC RESPONSE SHORTENED |
12 |
0.0004 |
| 927 |
NEUTROPENIA |
49 |
0.0004 |
| 928 |
MULTIPLE SCLEROSIS |
17 |
0.0004 |
| 929 |
MALIGNANT NEOPLASM PROGRESSION |
36 |
0.0004 |
| 930 |
INFUSION RELATED REACTION |
23 |
0.0003 |
| 931 |
PSORIATIC ARTHROPATHY |
14 |
0.0003 |
| 932 |
PSORIASIS |
45 |
0.0003 |
| 933 |
NEEDLE ISSUE |
10 |
0.0003 |
| 934 |
COGNITIVE DISORDER |
16 |
0.0003 |
| 935 |
CARDIO-RESPIRATORY ARREST |
14 |
0.0003 |
| 936 |
PANIC ATTACK |
12 |
0.0003 |
| 937 |
OSTEONECROSIS OF JAW |
8 |
0.0003 |
| 938 |
DERMATITIS ATOPIC |
17 |
0.0003 |
| 939 |
NERVOUS SYSTEM DISORDER |
10 |
0.0003 |
| 940 |
NEOPLASM PROGRESSION |
11 |
0.0003 |
| 941 |
MOOD SWINGS |
10 |
0.0003 |
| 942 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
11 |
0.0003 |
| 943 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
8 |
0.0003 |
| 944 |
FEBRILE NEUTROPENIA |
20 |
0.0003 |
| 945 |
VIRAL INFECTION |
10 |
0.0003 |
| 946 |
INJECTION SITE PRURITUS |
20 |
0.0003 |
| 947 |
ILL-DEFINED DISORDER |
18 |
0.0003 |
| 948 |
DISEASE RECURRENCE |
14 |
0.0003 |
| 949 |
ALANINE AMINOTRANSFERASE INCREASED |
18 |
0.0003 |
| 950 |
LIVER DISORDER |
13 |
0.0003 |
| 951 |
DEVICE DIFFICULT TO USE |
19 |
0.0003 |
| 952 |
CEREBRAL INFARCTION |
7 |
0.0003 |
| 953 |
NEOPLASM MALIGNANT |
19 |
0.0003 |
| 954 |
INJURY |
20 |
0.0003 |
| 955 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
13 |
0.0003 |
| 956 |
ABDOMINAL PAIN LOWER |
7 |
0.0003 |
| 957 |
ASCITES |
8 |
0.0003 |
| 958 |
ANAPHYLACTIC SHOCK |
7 |
0.0003 |
| 959 |
INJECTION SITE PAIN |
83 |
0.0003 |
| 960 |
OVERDOSE |
57 |
0.0003 |
| 961 |
AGGRESSION |
13 |
0.0003 |
| 962 |
DELIRIUM |
9 |
0.0003 |
| 963 |
GYNAECOMASTIA |
8 |
0.0003 |
| 964 |
VAGINAL HAEMORRHAGE |
11 |
0.0003 |
| 965 |
DEVICE DISLOCATION |
11 |
0.0003 |
| 966 |
ABNORMAL BEHAVIOUR |
10 |
0.0003 |
| 967 |
SUICIDAL IDEATION |
23 |
0.0003 |
| 968 |
INJECTION SITE MASS |
9 |
0.0002 |
| 969 |
HEPATIC FUNCTION ABNORMAL |
9 |
0.0002 |
| 970 |
LEUKOPENIA |
12 |
0.0002 |
| 971 |
INJECTION SITE BRUISING |
18 |
0.0002 |
| 972 |
INJECTION SITE SWELLING |
17 |
0.0002 |
| 973 |
MULTIPLE SCLEROSIS RELAPSE |
15 |
0.0002 |
| 974 |
DEVICE MALFUNCTION |
15 |
0.0002 |
| 975 |
CONVULSION |
12 |
0.0002 |
| 976 |
ANGIOEDEMA |
9 |
0.0002 |
| 977 |
LOWER RESPIRATORY TRACT INFECTION |
9 |
0.0002 |
| 978 |
DEVICE BREAKAGE |
8 |
0.0002 |
| 979 |
RHABDOMYOLYSIS |
8 |
0.0002 |
| 980 |
WITHDRAWAL SYNDROME |
8 |
0.0002 |
| 981 |
INJECTION SITE REACTION |
13 |
0.0002 |
| 982 |
PROSTATE CANCER |
15 |
0.0002 |
| 983 |
INJECTION SITE ERYTHEMA |
21 |
0.0002 |
| 984 |
BREAST CANCER |
14 |
0.0002 |
| 985 |
INTENTIONAL OVERDOSE |
8 |
0.0001 |
| 986 |
BLADDER CANCER |
7 |
0.0001 |
| 987 |
DRUG WITHDRAWAL SYNDROME |
10 |
0.0001 |
| 988 |
MATERNAL EXPOSURE DURING PREGNANCY |
8 |
0.0001 |
| 989 |
DRUG DEPENDENCE |
10 |
0.0001 |